METHOD FOR TREATMENT OF ACNE USING PHARMACEUTICAL COMPOSITIONS OF CLINDAMYCIN

The present invention relates to a method for treating, reducing or preventing acne. In particular, the present invention relates to methods for reducing the total number, incidence and severity of acne lesions on the skin which includes both inflammatory and non-inflammatory lesions. Further, the i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PANCHOLI, JINESH SURESH, SHEIKH, SHAFIQ, PATEL, JITENDRA DASHARATHLAL, KOTHARI, JAY SHANTILAL, MITTAL, RAVINDRA, ROY, SUNILENDU BHUSHAN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a method for treating, reducing or preventing acne. In particular, the present invention relates to methods for reducing the total number, incidence and severity of acne lesions on the skin which includes both inflammatory and non-inflammatory lesions. Further, the invention relates to reducing the incidence and severity of adverse events resulting from topical application of anti- acne agents resulting in improvement of skin tone. The method includes administering a novel and stable topical anti-acne pharmaceutical composition. L'invention concerne un procédé de traitement, de réduction ou de prévention de l'acné. L'invention concerne en particulier des procédés de réduction du nombre total, de l'incidence et de la gravité de lésions acnéiques de la peau, comprenant des lésions inflammatoires et des lésions non-inflammatoires. L'invention concerne également la réduction de l'incidence et de la gravité d'événements indésirables résultant de l'application topique d'agents anti-acné de manière à améliorer le teint. Le procédé consiste à administrer une nouvelle composition pharmaceutique anti-acné topique et stable.